Sleep and the immune system: Implications for health and mortality

Sleep & Safety

Volumn , Issue , 2011, Pages 52-59

  Balachandran, Diwakar ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867910647     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.2174/978160805271411101010052     Document Type: Chapter

References (60)

1. Banks S, Dinges DF. Behavioral and physiological consequences of sleep restriction. J Clin Sleep Med. 2007 Aug 15; 3 (5): 519-28.
2. Brunner DP, Dijk DJ, Borbely AA. Repeated partial sleep deprivation progressively changes in EEG during sleep and wakefulness. Sleep. 1993 Feb; 16 (2): 100-13.
3. Banks S, Dinges DF. Is the maintenance of wakefulness test sensitive to varying amounts of recovery sleep after chronic sleep restriction? Sleep. 2005 April; 28 (Abstract Supplement): A136.
4. Born J, Lange T, Hansen K, Molle M, Fehm HL. Effects of sleep and circadian rhythm on human circulating immune cells. J Immunol. 1997 May 1; 158 (9): 4454-64.
5. Spiegel K, Sheridan JF, Van Cauter E. Effect of sleep deprivation on response to immunization. JAMA. 2002 Sep 25; 288 (12): 1471-2.
6. Balachandran DD, Ewing SB, Murray BJ, LeBeau L, Mullington JM. Human host response during chronic partial sleep deprivation. Sleep. 2002 April; 25 (Abstract Supplement): A55.
7. Opp MR. Cytokines and sleep. Sleep Med Rev. 2005 Oct; 9 (5): 355-64.
8. Vgontzas AN, Zoumakis E, Bixler EO, Lin HM, Follett H, Kales A, et al. Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab. 2004 May; 89 (5): 2119-26.
9. Vgontzas AN, Papanicolaou DA, Bixler EO, Lotsikas A, Zachman K, Kales A, et al. Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab. 1999 Aug; 84 (8): 2603-7.
10. Shearer WT, Reuben JM, Mullington JM, Price NJ, Lee BN, Smith EO, et al. Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. J Allergy Clin Immunol. 2001 Jan; 107 (1): 165-70.
11. Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol. 2004 Feb 18; 43 (4): 678-83.
12. Simpson N, Dinges DF. Sleep and inflammation. Nutr Rev. 2007 Dec; 65 (12 Pt 2): S244-52.
13. Punjabi NM, Beamer BA. C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep. 2007 Jan 1; 30 (1): 29-34.
14. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab. 1997 May; 82 (5): 1313-6.
15. Dyugovskaya L, Lavie P, Lavie L. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Ann N Y Acad Sci. 2005 Jun; 1051: 340-50.
16. Burgos I, Richter L, Klein T, Fiebich B, Feige B, Lieb K, et al. Increased nocturnal interleukin-6 excretion in patients with primary insomnia: a pilot study. Brain Behav Immun. 2006 May; 20 (3): 246-53.
17. Vgontzas AN, Zoumakis M, Papanicolaou DA, Bixler EO, Prolo P, Lin HM, et al. Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime. Metabolism. 2002 Jul; 51 (7): 887-92.
18. Spath-Schwalbe E, Hansen K, Schmidt F, Schrezenmeier H, Marshall L, Burger K, et al. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J Clin Endocrinol Metab. 1998 May; 83 (5): 1573-9.
19. Krueger JM, Obal FJ, Fang J, Kubota T, Taishi P. The role of cytokines in physiological sleep regulation. Ann N Y Acad Sci. 2001 Mar; 933: 211-21.
20. Imeri L, Ceccarelli P, Mariotti M, Manfridi A, Opp MR, Mancia M. Sleep, but not febrile responses of Fisher 344 rats to immune challenge are affected by aging. Brain Behav Immun. 2004 Jul; 18 (4): 399-404.
21. Vgontzas AN, Zoumakis E, Lin HM, Bixler EO, Trakada G, Chrousos GP. Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab. 2004 Sep; 89 (9): 4409-13.
22. Imeri L, Opp MR. How (and why) the immune system makes us sleep. Nat Rev Neurosci. 2009 Mar; 10 (3): 199-210.
23. Opp MR. Sleep and psychoneuroimmunology. Immunol Allergy Clin North Am. 2009 May; 29 (2): 295-307.
24. Coogan AN, Wyse CA. Neuroimmunology of the circadian clock. Brain Res. 2008 Sep 26; 1232: 104-12.
25. Fencl V, Koski G, Pappenheimer JR. Factors in cerebrospinal fluid from goats that affect sleep and activity in rats. J Physiol. 1971 Aug; 216 (3): 565-89.
26. Krueger JM, Dinarello CA, Chedid L. Promotion of slow wave sleep (SWS) by a purified Interleukin-1 (IL-1) preparation. Fed Proc. 1983; 42: 356.
27. Dunn AJ. Effects of cytokines and infections on brain neurochemistry. Clin Neurosci Res. 2006 Aug; 6 (1-2): 52-68.
28. Takahashi S, Yokota S, Hara R, Kobayashi T, Akiyama M, Moriya T, et al. Physical and inflammatory stressors elevate circadian clock gene mPer1 mRNA levels in the paraventricular nucleus of the mouse. Endocrinology. 2001 Nov; 142 (11): 4910-7.
29. Okada K, Yano M, Doki Y, Azama T, Iwanaga H, Miki H, et al. Injection of LPS causes transient suppression of biological clock genes in rats. J Surg Res. 2008 Mar; 145 (1): 5-12.
30. Cavadini G, Petrzilka S, Kohler P, Jud C, Tobler I, Birchler T, et al. TNF-alpha suppresses the expression of clock genes by interfering with E-box-mediated transcription. Proc Natl Acad Sci U S A. 2007 Jul 31; 104 (31): 12843-8.
31. Nygard M, Hill RH, Wikstrom MA, Kristensson K. Age-related changes in electrophysiological properties of the mouse suprachiasmatic nucleus in vitro. Brain Res Bull. 2005 Mar 15; 65 (2): 149-54.
32. Gangwisch JE, Malaspina D, Boden-Albala B, Heymsfield SB. Inadequate sleep as a risk factor for obesity: analyses of the NHANES I. Sleep. 2005 Oct 1; 28 (10): 1289-96.
33. Spiegel K, Leproult R, Colecchia EF, L'Hermite-Baleriaux M, Nie Z, Copinschi G, et al. Adaptation of the 24-h growth hormone profile to a state of sleep debt. Am J Physiol Regul Integr Comp Physiol. 2000 Sep; 279 (3): R874-83.
34. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999 Oct 23; 354 (9188): 1435-9.
35. Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med. 2004 Dec; 1 (3): e62.
36. Pukkala E, Auvinen A, Wahlberg G. Incidence of cancer among Finnish airline cabin attendants, 1967-92. BMJ. 1995 Sep 9; 311 (7006): 649-52.
37. Kojo K, Pukkala E, Auvinen A. Breast cancer risk among Finnish cabin attendants: a nested case-control study. Occup Environ Med. 2005 Jul; 62 (7): 488-93.
38. Davis S, Mirick DK, Stevens RG. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst. 2001 Oct 17; 93 (20): 1557-62.
39. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, et al. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst. 2001 Oct 17; 93 (20): 1563-8.
40. Viswanathan AN, Hankinson SE, Schernhammer ES. Night shift work and the risk of endometrial cancer. Cancer Res. 2007 Nov 1; 67 (21): 10618-22.
41. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, et al. Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst. 2003 Jun 4; 95 (11): 825-8.
42. Kubo T, Ozasa K, Mikami K, Wakai K, Fujino Y, Watanabe Y, et al. Prospective cohort study of the risk of prostate cancer among rotating-shift workers: findings from the Japan collaborative cohort study. Am J Epidemiol. 2006 Sep 15; 164 (6): 549-55.
43. Stevens RG. Electric power use and breast cancer: a hypothesis. Am J Epidemiol. 1987 Apr; 125 (4): 556-61.
44. Schernhammer ES, Schulmeister K. Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels? Br J Cancer. 2004 Mar 8; 90 (5): 941-3.
45. Bryant PA, Trinder J, Curtis N. Sick and tired: Does sleep have a vital role in the immune system? Nat Rev Immunol. 2004 Jun; 4 (6): 457-67.
46. Davidson JR, Waisberg JL, Brundage MD, MacLean AW. Nonpharmacologic group treatment of insomnia: a preliminary study with cancer survivors. Psychooncology. 2001 Sep-Oct; 10 (5): 389-97.
47. Ancoli-Israel S, Moore PJ, Jones V. The relationship between fatigue and sleep in cancer patients: a review. Eur J Cancer Care (Engl). 2001 Dec; 10 (4): 245-55.
48. Holzner B, Kemmler G, Kopp M, Nguyen-Van-Tam D, Sperner-Unterweger B, Greil R. Quality of life of patients with chronic lymphocytic leukemia: results of a longitudinal investigation over 1 yr. Eur J Haematol. 2004 Jun; 72 (6): 381-9.
49. Roscoe JA, Kaufman ME, Matteson-Rusby SE, Palesh OG, Ryan JL, Kohli S, et al. Cancer-related fatigue and sleep disorders. Oncologist. 2007; 12 Suppl 1: 35-42.
50. Wood LJ, Nail LM, Gilster A, Winters KA, Elsea CR. Cancer chemotherapy-related symptoms: evidence to suggest a role for proinflammatory cytokines. Oncol Nurs Forum. 2006 May; 33 (3): 535-42.
51. Vena C, Parker K, Cunningham M, Clark J, McMillan S. Sleep-wake disturbances in people with cancer part I: an overview of sleep, sleep regulation, and effects of disease and treatment. Oncol Nurs Forum. 2004 Jul; 31 (4): 735-46.
52. Payne J, Piper B, Rabinowitz I, Zimmerman B. Biomarkers, fatigue, sleep, and depressive symptoms in women with breast cancer: a pilot study. Oncol Nurs Forum. 2006 Jul; 33 (4): 775-83.
53. Kapsimalis F, Basta M, Varouchakis G, Gourgoulianis K, Vgontzas A, Kryger M. Cytokines and pathological sleep. Sleep Med. 2008 Aug; 9 (6): 603-14.
54. Hastings MH, Herzog ED. Clock genes, oscillators, and cellular networks in the suprachiasmatic nuclei. J Biol Rhythms. 2004 Oct; 19 (5): 400-13.
55. Savard J, Liu L, Natarajan L, Rissling MB, Neikrug AB, He F, et al. Breast cancer patients have progressively impaired sleep-wake activity rhythms during chemotherapy. Sleep. 2009 Sep 1; 32 (9): 1155-60.
56. Berger AM, Wielgus K, Hertzog M, Fischer P, Farr L. Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy. Support Care Cancer. 2009 Apr 19.
57. Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry. 2002 Feb; 59 (2): 131-6.
58. Ayas NT, White DP, Manson JE, Stampfer MJ, Speizer FE, Malhotra A, et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med. 2003 Jan 27; 163 (2): 205-9.
59. Qureshi AI, Giles WH, Croft JB, Bliwise DL. Habitual sleep patterns and risk for stroke and coronary heart disease: a 10- year follow-up from NHANES I. Neurology. 1997 Apr; 48 (4): 904-11.
60. Gallicchio L, Kalesan B. Sleep duration and mortality: a systematic review and meta-analysis. J Sleep Res. 2009 Jun; 18 (2): 148-58.